Machine learning approaches for customized docking scores: Modeling of inhibition of Mycobacterium tuberculosis enoyl acyl carrier protein reductase

Machine learning algorithms were used for feature selection and model generation of customized docking score functions for known inhibitors of Mycobacterium tuberculosis enoyl acyl carrier protein reductase. The features included small molecule descriptors derived from MOE, Accord, and Molegro as well as in silico docking energies/scores from GOLD and Autodock. The resulting models can be used to identify key descriptors for enoyl acyl carrier protein reductase inhibition and are useful for high-throughput screening of novel drug compounds. This paper also evaluates and contrasts several strategies for model generation for quantitative structure-activity relationships.

[1]  R. Kroemer Structure-based drug design: docking and scoring. , 2007, Current protein & peptide science.

[2]  J. Musser,et al.  Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[3]  Christopher R. Corbeil,et al.  Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go , 2008, British journal of pharmacology.

[4]  D. Hecht,et al.  High-Throughput Ligand Screening via Preclustering and Evolved Neural Networks , 2007, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[5]  W. Jacobs,et al.  inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. , 1994, Science.

[6]  Robert Stroud,et al.  Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. , 2006, Journal of medicinal chemistry.

[7]  T. Halgren Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..

[8]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[9]  P. Ortiz de Montellano,et al.  Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. , 2007, Bioorganic & medicinal chemistry.

[10]  G. Besra,et al.  Pathway to Synthesis and Processing of Mycolic Acids in Mycobacterium tuberculosis , 2005, Clinical Microbiology Reviews.

[11]  Gary B. Fogel,et al.  High-Throughput Ligand Screening via Preclustering and Evolved Neural Networks , 2007, IEEE ACM Trans. Comput. Biol. Bioinform..

[12]  J. T. Crawford,et al.  ethA, inhA, and katG Loci of Ethionamide-Resistant Clinical Mycobacterium tuberculosis Isolates , 2003, Antimicrobial Agents and Chemotherapy.

[13]  René Thomsen,et al.  MolDock: a new technique for high-accuracy molecular docking. , 2006, Journal of medicinal chemistry.

[14]  Włodzisław Duch,et al.  Artificial intelligence approaches for rational drug design and discovery. , 2007, Current pharmaceutical design.

[15]  Jian Zhang,et al.  Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score. , 2005, Journal of combinatorial chemistry.

[16]  Eric J Martin,et al.  Target-biased scoring approaches and expert systems in structure-based virtual screening. , 2004, Current opinion in chemical biology.

[17]  D. C. Sullivan,et al.  Exploiting Structure—Activity Relationships in Docking. , 2008 .

[18]  Shan Chang,et al.  Complex-type-dependent scoring functions in protein-protein docking. , 2007, Biophysical chemistry.

[19]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[20]  David H. Wolpert,et al.  No free lunch theorems for optimization , 1997, IEEE Trans. Evol. Comput..

[21]  Gary B. Fogel,et al.  QSAR using evolved neural networks for the inhibition of mutant PfDHFR by pyrimethamine derivatives , 2008, Biosyst..

[22]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.